We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
-15.38%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
AUM
$605M
AUM Growth
-$43.1M
Cap. Flow
+$70M
Cap. Flow %
11.58%
Top 10 Hldgs %
48.94%
Holding
2,904
New
349
Increased
1,175
Reduced
755
Closed
206

Sector Composition

Rank Sector Weight
1 Financials 18.89%
2 Technology 11.62%
3 Healthcare 5.08%
4 Consumer Discretionary 3.93%
5 Energy 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATRA icon
1901
Atara Biotherapeutics
ATRA
$76.1M
$2K ﹤0.01%
+10
New +$1.63K
AVIR icon
1902
Atea Pharmaceuticals
AVIR
$420M
$2K ﹤0.01%
+313
New +$2.14K
AVNT icon
1903
Avient
AVNT
$4.19B
$2K ﹤0.01%
53
-3
-5% -$142
AXGN icon
1904
Axogen
AXGN
$2.5B
$2K ﹤0.01%
+196
New +$1.68K
AZUL
1905
DELISTED
Azul
AZUL
$2K ﹤0.01%
265
-230
-46% -$2.77K
BAND
1906
Bandwidth Inc
BAND
$1.61B
$2K ﹤0.01%
106
-87
-45% -$2.01K
BATRA icon
1907
Atlanta Braves Holdings Series A
BATRA
$3.43B
$2K ﹤0.01%
77
BB icon
1908
BlackBerry
BB
$5.26B
$2K ﹤0.01%
289
-942
-77% -$5.59K
BCRX icon
1909
BioCryst Pharmaceuticals
BCRX
$2.4B
$2K ﹤0.01%
218
-8
-4% -$83
BRBR icon
1910
BellRing Brands
BRBR
$1.34B
$2K ﹤0.01%
76
-3
-4% -$73
BRKL
1911
DELISTED
Brookline Bancorp
BRKL
$2K ﹤0.01%
157
BRO icon
1912
Brown & Brown
BRO
$23.9B
$2K ﹤0.01%
42
+8
+24% +$491
BSY icon
1913
Bentley Systems
BSY
$10.6B
$2K ﹤0.01%
70
+32
+84% +$1.18K
BVS icon
1914
Bioventus
BVS
$1.19B
$2K ﹤0.01%
+232
New +$2.37K
BW icon
1915
Babcock & Wilcox
BW
$1.39B
$2K ﹤0.01%
269
+36
+15% +$252
BXP icon
1916
Boston Properties
BXP
$11.1B
$2K ﹤0.01%
24
+13
+118% +$1.44K
BBBY
1917
Bed Bath & Beyond
BBBY
$442M
$2K ﹤0.01%
78
+30
+63% +$902
CARS icon
1918
Cars.com
CARS
$660M
$2K ﹤0.01%
170
+54
+47% +$583
CCRN
1919
DELISTED
Cross Country Healthcare
CCRN
$2K ﹤0.01%
83
-104
-56% -$1.95K
CDE icon
1920
Coeur Mining
CDE
$17.9B
$2K ﹤0.01%
556
+397
+250% +$1.56K
CEF icon
1921
Sprott Physical Gold and Silver Trust
CEF
$8.06B
$2K ﹤0.01%
125
CGEM icon
1922
Cullinan Oncology
CGEM
$1.14B
$2K ﹤0.01%
178
+33
+23% +$374
CMPS
1923
Compass Pathways
CMPS
$1.83B
$2K ﹤0.01%
+144
New +$1.45K
COLL icon
1924
Collegium Pharmaceutical
COLL
$956M
$2K ﹤0.01%
104
-77
-43% -$1.29K
CORT icon
1925
Corcept Therapeutics
CORT
$12B
$2K ﹤0.01%
96

Similar funds

Lindbrook Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Lindbrook Capital held 2,904 positions worth $605M, down 6.6% from $648M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Lindbrook Capital deployed $70M of net new capital in Q2 2022, opening 349 new positions and adding to 1,175 existing holdings. Its largest new stake was BlackRock MuniHoldings California Quality Fund: 50,522 shares worth $605K.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Digital Turbine, an estimated $3.57M trimmed.

  • Lindbrook Capital's largest Q2 2022 buy was BlackRock MuniHoldings California Quality Fund: 50,522 shares worth $605K.
  • Lindbrook Capital added most to Golub Capital BDC in Q2 2022, an estimated $26.1M increase.
  • Lindbrook Capital's biggest Q2 2022 reduction was Digital Turbine, cutting an estimated $3.57M.
  • Lindbrook Capital fully exited Berkshire Hathaway Class A in Q2 2022, selling an estimated $1.06M.
  • Lindbrook Capital's ten largest holdings make up 49% of its $605M portfolio in Q2 2022.
  • Lindbrook Capital opened 349 new positions and closed 206 in Q2 2022.
  • Lindbrook Capital's portfolio value fell 6.6% quarter-over-quarter to $605M.

Based on Lindbrook Capital's 13F filing for Q2 2022, filed 1 Aug 2022.